US2009324733A1PendingUtilityA1
Composition of Whey Growth Factor Extract for Reducing Muscle Inflammation
Assignee: MURRAY GOULBURN CO OPEARTIVE CPriority: Sep 9, 2005Filed: Sep 8, 2006Published: Dec 31, 2009
Est. expirySep 9, 2025(expired)· nominal 20-yr term from priority
A61P 29/00A61P 21/00A23L 33/19A23V 2300/30A23C 21/06A23J 1/205A61K 38/1709A23V 2002/00A61K 35/20A23L 33/40A61K 38/18
37
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention relates to the production of compositions containing milk products for use as a nutritional supplement. More specifically, it relates to compositions containing whey growth factor extract, as well as their use in methods for reducing muscle inflammation in individuals undertaking resistance exercise training. According to one aspect of the invention, there is provided the use of a composition comprising whey growth factor extract, isolated from a milk product by cation exchange chromatography, to reduce exercise-induced muscle inflammation.
Claims
exact text as granted — not AI-modified1 . A muscle anti-inflammatory composition comprising whey growth factor extract, isolated from a milk product by cation exchange chromatography.
2 . A muscle anti-inflammatory composition comprising whey growth factor extract, isolated from a milk product by a process comprising the steps;
a) applying the milk product to a SP Sepharose cation exchange column, b) washing the column with a buffer of low ionic strength, c) eluting the WGFE fraction with a buffer containing in the range 0.4-0.5M NaCl, or equivalent ionic strength, at pH 6.5.
3 . A muscle anti-inflammatory composition comprising whey growth factor extract, isolated from skim milk by a process comprising the steps;
a) applying the skim milk to a SP Sepharose cation exchange column, b) washing the column with a buffer of less than 0.008M NaCl, c) eluting the WGFE fraction with a buffer containing 0.4M NaCl, at pH 6.5.
4 . The muscle anti-inflammatory composition as claimed in any one of claims 1 to 3 , further comprising an additional protein source.
5 . The composition of claim 4 , wherein the additional protein source is whey protein.
6 . The composition of claim 5 , wherein the whey protein is whey protein isolate (WPI).
7 . The composition of claim 6 , wherein the whey protein isolate comprises:
Moisture
5.0%
Fat
0.5%
pH (5% solution)
6.3
Ash
3.7%
Lactose
0.5%
Protein (TN × 6.38)
90.0%
Sodium
0.7%
Phosphorous
0.3%
Calcium
0.15%
8 . The composition of any one of claims 1 to 3 , wherein the whey growth factor extract is isolated from a source selected from the group consisting of cheese whey, rennet casein whey, acid casein whey and skim milk.
9 . The composition of claim 8 , wherein the whey growth factor extract is isolated from skim milk.
10 . A composition according to any one of claims 1 to 3 , when used as a muscle anti-inflammatory agent.
11 . A method of reducing muscle inflammation in a subject undertaking resistance exercise training comprising administering to the subject a composition comprising an effective amount of the muscle strength-enhancing composition of any one of claims 1 to 3 .
12 . The method of claim 11 wherein the composition is administered in a daily dose of at least 5 mg/kg body weight to 12.5 mg/kg body weight whey growth factor extract.
13 . The method of claim 11 , wherein the composition comprises an additional protein source.
14 . A method of reducing muscle inflammation in a subject undertaking resistance exercise training comprising administering to the subject a composition comprising an effective amount of whey growth factor extract, isolated from a milk product by cation exchange chromatography, and an additional protein source taken separately.
15 . The method of claim 13 or 14 , wherein the composition is administered in a daily dose of at least 5 mg/kg body weight to 12.5 mg/kg body weight whey growth factor extract, and at least 225 mg/kg body weight of additional protein source.
16 . The method of claim 15 wherein the additional protein source is whey protein.
17 . The method of claim 14 , wherein the administration to the subject is once per two or three days up to at least once per day.
18 . The method of claim 14 , wherein the administration to the subject is before, and/or immediately after, resistance exercise training.
19 . The method of claim 14 , wherein the administration is immediately after resistance exercise training.
20 . The method of claim 18 , wherein the administration is between 20 minutes and two hours after exercise.
21 . A method of treating resistance exercise induced muscle inflammation in a subject, the method comprising administering to the subject whey growth factor extract, isolated from a milk product by cation exchange chromatography.
22 . A method of treating resistance exercise induced muscle inflammation in a subject, the method comprising administering to the subject whey growth factor extract, isolated from a milk product by a process according to claim 2 or 3 .
23 . A method of treating resistance exercise induced muscle inflammation in a subject, the method comprising administering to the subject the composition of any one of claims 1 to 3 .
24 . A food, drink, tablet or capsule comprising the composition of any one of claims 1 to 3 .
25 . The food of claim 24 , being in the form of a nutritional bar or snack food.
26 . A method of manufacturing a food, drink, tablet or capsule reduce muscle inflammation in a subject undertaking resistance exercise training the method comprising manufacturing the composition of any one of claims 1 to 3 .
27 - 29 . (canceled)Join the waitlist — get patent alerts
Track US2009324733A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.